COMPARISON OF FLUDARABINE, CYCLOPHOSPHAMIDE DOXORUBICIN PREDNISONE, AND CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE IN ADVANCED FORMS OF CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS OF A CONTROLLED CLINICAL-TRIAL

FENAUX P BINET JL MALOUM K LEPORRIER M RAPP MJ PIGUET H BRION A BOUDJERRA N DREYFUS B LEBLAY R STOPPA AM AUTRAND JP SEBBAN C PAITEL JF MAISONNEUVE P ROUSSET T LINASSIER M BRICE P TRAVADE P DIVINE M DESABLENS B JAUBERT J ALLARD C CHERON D EGHBALI JP CELIGNY PS BORDESSOULE D PIGNON B VAUGIER G LEJEUNE F SALLES B DEVIDAS M BLANC M MAIGRE M REIGNER A SIMON P CHRISTIAN B SCHVED JF DOIRON P RODON M CARDE P YAKOUB I SOUTEYRAND P RENOUX M FACQUETDANIS J HAMIDOU M TURPIN F DOR JF FERMAND JP VIGNERON N GARNIER A LELOSTER JP CHEVRET S CHASTING C

P. Fenaux et al., COMPARISON OF FLUDARABINE, CYCLOPHOSPHAMIDE DOXORUBICIN PREDNISONE, AND CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE IN ADVANCED FORMS OF CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS OF A CONTROLLED CLINICAL-TRIAL, Seminars in oncology, 20(5), 1993, pp. 21-23

4

Oncology

Seminars in oncology → ACNP

00937754

20

5

1993

7

21 - 23

ISI

0093-7754(1993)20:5<21:COFCDP>2.0.ZU;2-W